Business
Press Release Mar 30 2023
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Brimonidine Tartrate Ophthalmic Solution, 0.15%.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 30, 2023, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Brimonidine Tartrate Ophthalmic Solution, 0.15%.\". View Attachment","length":416,"tagName":"div"}]